{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-005519","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.026508+00:00","generated_at":"2026-06-13T03:03:22.455322+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cosmos Health raises $5.25M via registered direct offering and private placement; CEO participates $450K","bullets":["Issued 2,116,936 common shares, 715,323 pre-funded warrants, and 1,935,484 common warrants in a $5.25M offering.","Combined purchase price per share and warrant was $2.48; common warrant exercise price $2.75, expiring in 5 years.","CEO Grigorios Siokas invested $450,000 in common shares; no warrants issued to him.","Existing warrants on 782,610 shares amended: exercise price reduced from $11.50 to $2.75 per share.","Net proceeds primarily for working capital, general corporate purposes, and funding acquisitions."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-005519","json":"https://secwatch.observer/filing/0001477932-23-005519.json","markdown":"https://secwatch.observer/filing/0001477932-23-005519.md","text":"https://secwatch.observer/filing/0001477932-23-005519.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223005519/0001477932-23-005519-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223005519/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T03:03:22.455322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b7c362f0be3e698fa3acab4f156b4859ef043db","claim":"Cosmos Health Inc. entered into Securities Purchase Agreement with certain institutional investors and existing shareholders valued at approximately $5,250,000 (effective 2023-07-20).","evidence_excerpt":"On July 20, 2023, Cosmos Health Inc. (“we,” “our,” “us,” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors and existing shareholders (the “Purchasers”), for a registered direct offering and a concurrent private placement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223005519/0001477932-23-005519-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors and existing shareholders"},{"label":"Value","value":"approximately $5,250,000"},{"label":"Effective","value":"2023-07-20"}],"fact_type":"material_agreement"},{"claim_id":"9079ea0abfa51794d1e5c7d606a5f9ef85882321","claim":"Cosmos Health Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (effective 2023-07-20).","evidence_excerpt":"Pursuant to a Placement Agency Agreement dated July 20, 2023, the Company engaged A.G.P./Alliance Global Partners as sole Placement Agent in connection with the Offering.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223005519/0001477932-23-005519-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Effective","value":"2023-07-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}